SEC Form 4 · accession 0001209191-17-049519
Myovant Sciences Ltd. · MYOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ferreira Juan Camilo Arjona
Officer — Chief Medical Officer
Period of report
Aug 15, 2017
Accepted (ET)
Aug 17, 2017 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1,F2 | Aug 15, 2017 | A | 10,000 | $0.00 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $10.60 | Aug 15, 2017 | A | 260,000 | A | — | Aug 14, 2027 | Common Shares | 260,000 | 260,000 | D |
Explanation of responses
- F1Represents common shares underlying a restricted stock unit award.
- F21/4 of the common shares underlying this restricted stock unit award vest on August 16, 2018, and 1/16 of the common shares underlying this restricted stock unit award vest on each November 16, February 16, July 1 and August 16 thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.
- F31/4 of the common shares underlying this option vest on August 15, 2018, and 1/16 of the common shares underlying this option vest at the end of each quarter thereafter measured from August 15, 2018, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.